Literature DB >> 9204299

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine.

H E de Melker1, M A Conyn-van Spaendonck, H C Rümke, J K van Wijngaarden, F R Mooi, J F Schellekens.   

Abstract

In 1996, a sudden increase in pertussis incidence was reported in the Netherlands (2.1 per 100,000 in 1995, 18 per 100,000 in 1996). Although not all potential surveillance artifacts could be excluded, it is highly probable that the data reflect a true outbreak. However, the cause of this increase has not yet been determined. Further research is directed to the severity of disease and a possible mismatch between the vaccine and the circulating Bordetella strains.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9204299      PMCID： PMC2627603          DOI： 10.3201/eid0302.970211

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN： 1080-6040            Impact factor:   6.883


  7 in total

1.  A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population.

Authors:  A van der Zee; C Agterberg; M Peeters; F Mooi; J Schellekens
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

2.  Dynamics of the population structure of Bordetella pertussis as measured by IS1002-associated RFLP: comparison of pre- and post-vaccination strains and global distribution.

Authors:  A van der Zee; S Vernooij; M Peeters; J van Embden; F R Mooi
Journal:  Microbiology       Date:  1996-12       Impact factor: 2.777

3.  Resurgence of pertussis in Montérégie, Quebec--1990-1994.

Authors:  F Milord
Journal:  Can Commun Dis Rep       Date:  1995-03-15

4.  Pertussis in Quebec: ongoing epidemic since the late 1980s.

Authors:  G De Serres; N Boulianne; M Douville Fradet; B Duval
Journal:  Can Commun Dis Rep       Date:  1995-03-15

5.  A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

Authors:  D Greco; S Salmaso; P Mastrantonio; M Giuliano; A E Tozzi; A Anemona; M L Ciofi degli Atti; A Giammanco; P Panei; W C Blackwelder; D L Klein; S G Wassilak
Journal:  N Engl J Med       Date:  1996-02-08       Impact factor: 91.245

6.  [Whooping cough in The Netherlands, 1989-1994].

Authors:  H E de Melker; M A Conyn-van Spaendonck; H C Rümke; M J Sprenger; J F Schellekens
Journal:  Ned Tijdschr Geneeskd       Date:  1995-06-24

7.  Pertussis--United States, January 1992-June 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-07-21       Impact factor: 17.586
  7 in total
  43 in total

1.  Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years.

Authors:  C Weber; C Boursaux-Eude; G Coralie; V Caro; N Guiso
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

2.  Multilocus sequence typing of Bordetella pertussis based on surface protein genes.

Authors:  Inge H M van Loo; Kees J Heuvelman; Audrey J King; Frits R Mooi
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

3.  Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland.

Authors:  F R Mooi; Q He; H van Oirschot; J Mertsola
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Strain variation among Bordetella pertussis isolates from Québec and Alberta provinces of Canada from 1985 to 1994.

Authors:  Mark S Peppler; Sharee Kuny; Anna Nevesinjac; Christina Rogers; Yvon R de Moissac; Kathleen Knowles; Manon Lorange; Gaston De Serres; James Talbot
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

5.  Epidemiology and characterization of Bordetella parapertussis strains isolated between 1995 and 2002 in and around Warsaw, Poland.

Authors:  I Letowska; W Hryniewicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-05-27       Impact factor: 3.267

6.  Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles.

Authors:  Abdolreza Advani; Declan Donnelly; Hans Hallander
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

7.  Immunoglobulin A-mediated protection against Bordetella pertussis infection.

Authors:  S M Hellwig; A B van Spriel; J F Schellekens; F R Mooi; J G van de Winkel
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

8.  Antigenic divergence of Bordetella pertussis isolates in Taiwan.

Authors:  Shu-Man Yao; Yu-Chi Lin; Chen-Ying Chou; Ying-Yan Chen; Miao-Ju Hsiao; Hour-Young Chen; Jer-Jea Yan; Hsun-Pi Su; Shu-Ying Li
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

9.  Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.

Authors:  Rob J Vandebriel; Eric R Gremmer; Michiel van Hartskamp; Jan A M A Dormans; Frits R Mooi
Journal:  Clin Vaccine Immunol       Date:  2007-01-03

Review 10.  Childhood immunisation today.

Authors:  J Eskola
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.